Multi-Center Clinical Trial Results of Laser Scleral Microporation in Presbyopic Eyes | ASCRS
Presentation
Multi-Center Clinical Trial Results of Laser Scleral Microporation in Presbyopic Eyes
May 2020
Meeting: 2020 Virtual Annual Meeting
Session: SPS-107 Presbyopia Correction II
Authors: Mitchell A. Jackson, MD, ABO, AnnMarie Hipsley PhD, David Ma MD, PhD, Robert Edward Ang MD, Sunil Shah MD, FRCS, Brad Hall PhD
This content is only available for ASCRS Members

This content from the 2020 ASCRS Virtual Annual Meeting is only available to ASCRS members. To log in, click the teal "Login" button in the upper right-hand corner of this page.

Purpose
To evaluate changes in visual outcomes in presbyopic eyes after Laser Scleral Microporation (LSM).

Methods
An Er:YAG laser was used in 4 quadrants on the sclera to improve pliability & biomechanical efficiency of the ciliary muscles in 3 critical zones, for 20 patients. Patients were over 40 years of age and showed loss of accommodative ability. Visual outcomes were assessed using the Early Diabetic Retinopathy Study (EDTRS) logMAR charts, randot stereopsis, and intraocular pressure (IOP) was also assessed using a pneumatic tonometer before and after the procedure.

Results
LSM provided improvement in both uncorrected and distance corrected intermediate (UIVA, DCIVA) and near visual acuity (UNVA, DCNVA) with no significant changes to their distance vision. Early results demonstrated that patients receive 5 lines of improvement in their binocular UNVA at 1 month postoperatively, compared to preoperative UNVA. Patients also showed improvement in stereopsis postoperatively.

Conclusion
Early clinical trial results suggest LSM to be a safe and effective procedure for restoring range of visual performance in presbyopes. Early results also suggest that LSM can improve intermediate and near visual acuity without touching the visual axis and without comprising distance vision or stereopsis. Data collection is ongoing.
View More Presentations from this Session

This presentation is from the session "SPS-107 Presbyopia Correction II" from the 2020 ASCRS Virtual Annual Meeting held on May 16-17, 2020.

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.